154 related articles for article (PubMed ID: 12908947)
1. Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study.
Dams R; De Letter EA; Mortier KA; Cordonnier JA; Lambert WE; Piette MH; Van Calenbergh S; De Leenheer AP
J Anal Toxicol; 2003; 27(5):318-22. PubMed ID: 12908947
[TBL] [Abstract][Full Text] [Related]
2. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.
Mortier KA; Dams R; Lambert WE; De Letter EA; Van Calenbergh S; De Leenheer AP
Rapid Commun Mass Spectrom; 2002; 16(9):865-70. PubMed ID: 11948818
[TBL] [Abstract][Full Text] [Related]
3. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report.
Fineschi V; Masti A
Int J Legal Med; 1996; 108(5):272-5. PubMed ID: 8721431
[TBL] [Abstract][Full Text] [Related]
4. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives.
Forrest AR; Galloway JH; Marsh ID; Strachan GA; Clark JC
Forensic Sci Int; 1994 Jan; 64(1):57-9. PubMed ID: 7908887
[TBL] [Abstract][Full Text] [Related]
5. Distribution study of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine in a fatal overdose.
De Letter EA; Clauwaert KM; Lambert WE; Van Bocxlaer JF; De Leenheer AP; Piette MH
J Anal Toxicol; 2002 Mar; 26(2):113-8. PubMed ID: 11924548
[TBL] [Abstract][Full Text] [Related]
6. Fatality due to the use of a designer drug MDMA (Ecstasy).
Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E
Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458
[TBL] [Abstract][Full Text] [Related]
7. Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia.
Chadwick IS; Curry PD; Linsley A; Freemont AJ; Doran B
J R Soc Med; 1991 Jun; 84(6):371. PubMed ID: 1676424
[No Abstract] [Full Text] [Related]
8. [Poisoning with amphetamines and designer drugs].
Felgenhauer N; Zilker T
Internist (Berl); 1999 Jun; 40(6):617-23. PubMed ID: 10420315
[No Abstract] [Full Text] [Related]
9. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities.
De Letter EA; Bouche MP; Van Bocxlaer JF; Lambert WE; Piette MH
Forensic Sci Int; 2004 May; 141(2-3):85-90. PubMed ID: 15062945
[TBL] [Abstract][Full Text] [Related]
10. "ADAM' or "EVE'?--a toxicological conundrum.
Cox DE; Williams KR
Forensic Sci Int; 1996 Jan; 77(1-2):101-8. PubMed ID: 8675130
[TBL] [Abstract][Full Text] [Related]
11. Three cases of fatal paramethoxyamphetamine overdose.
Martin TL
J Anal Toxicol; 2001 Oct; 25(7):649-51. PubMed ID: 11599618
[TBL] [Abstract][Full Text] [Related]
12. MDEA related death in Crete: a case report and literature review.
Tsatsakis AM; Michalodimitrakis MN; Patsalis AN
Vet Hum Toxicol; 1997 Aug; 39(4):241-4. PubMed ID: 9251177
[TBL] [Abstract][Full Text] [Related]
13. Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose.
García-Repetto R; Moreno E; Soriano T; Jurado C; Giménez MP; Menéndez M
Forensic Sci Int; 2003 Aug; 135(2):110-4. PubMed ID: 12927411
[TBL] [Abstract][Full Text] [Related]
14. "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.
Rojek S; Kłys M; Strona M; Maciów M; Kula K
Forensic Sci Int; 2012 Oct; 222(1-3):e1-6. PubMed ID: 22648055
[TBL] [Abstract][Full Text] [Related]
15. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
Moore KA; Mozayani A; Fierro MF; Poklis A
Forensic Sci Int; 1996 Dec; 83(2):111-9. PubMed ID: 9022274
[TBL] [Abstract][Full Text] [Related]
16. Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
Rasmussen LB; Olsen KH; Johansen SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 842(2):136-41. PubMed ID: 16797258
[TBL] [Abstract][Full Text] [Related]
17. Treating MDMA ('Ecstasy') toxicity.
Padkin A
Anaesthesia; 1994 Mar; 49(3):259. PubMed ID: 7908506
[No Abstract] [Full Text] [Related]
18. Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland.
De Letter EA; Espeel MF; Craeymeersch ME; Lambert WE; Clauwaert KM; Dams R; Mortier KA; Piette MH
Int J Legal Med; 2003 Feb; 117(1):2-9. PubMed ID: 12592588
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine.
Ketabi-Kiyanvash N; Weiss J; Haefeli WE; Mikus G
Addict Biol; 2003 Dec; 8(4):413-8. PubMed ID: 14690877
[TBL] [Abstract][Full Text] [Related]
20. Fatal intoxication involving etryptamine.
Morano RA; Spies C; Walker FB; Plank SM
J Forensic Sci; 1993 May; 38(3):721-5. PubMed ID: 8099943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
